Robbins Arroyo LLP

Halozyme Therapeutics, Inc.

Robbins Arroyo LLP Is Investigating the Officers and Directors of Halozyme Therapeutics, Inc. on Behalf of Shareholders

Imperva Inc.

Attention Imperva, Inc. Investors: Imperva Misled Investors According to a Recently Filed Class Action

Zygo Corporation

Acquisition of Zygo Corporation by AMETEK, Inc. May Not Be in Shareholders’ Best Interests

Genworth Financial, Inc.

Attention Genworth Financial, Inc. Investors: Genworth Misled Investors According to a Recently Filed Class Action

Allied Nevada Gold Corp.

Attention Allied Nevada Gold Corp. Investors: Allied Nevada Misled Investors According to a Recently Filed Class Action

Questcor Pharmaceuticals, Inc.

Acquisition of Questcor Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders’ Best Interests

DFC Global Corp.

Attention DFC Global Corp. Investors: DFC Global Misled Investors According to a Newly Filed Class Action

Altisource Residential Corp.

Robbins Arroyo LLP Is Investigating the Officers and Directors of Altisource Residential Corporation on Behalf of Shareholders

SWS Group Inc.

Acquisition of SWS Group, Inc. by Hilltop Holdings, Inc. May Not Be in Shareholders’ Best Interests

Och-Ziff

Robbins Arroyo LLP Is Investigating the Officers and Directors of Och-Ziff Capital Management Group LLC on Behalf of Shareholders

Advanced Emissions Solutions

Attention Advanced Emission Solutions, Inc. Investors: Law Firm Investigates on Behalf of Shareholders

Checkpoint Systems, Inc.

Robbins Arroyo LLP Is Investigating the Officers and Directors of Checkpoint Systems, Inc. on Behalf of Shareholders

World Acceptance Corporation

Robbins Arroyo LLP Is Investigating the Officers and Directors of World Acceptance Corporation on Behalf of Shareholders

Tower Group International, Ltd.

Robbins Arroyo LLP announce that the firm filed a class action lawsuit on February 27, 2014, in the U.S. District Court, Southern District of New York (the “Court”), on behalf of the shareholders of Tower Group...

Galena Biopharma

Attention Galena Biopharma, Inc. Investors: Galena Misled Investors According to a Recently Filed Class Action

Time Warner Cable Inc.

Acquisition of Time Warner Cable Inc. by Comcast Corporation May Not Be in Shareholders’ Best Interests